Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
38
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kiss Szilard | Director | 10 | $0 | $0 | 2025-12-09 |
| Hong Soo | Director | 8 | $0 | $0 | 2025-12-09 |
| Seyedkazemi Setareh | Chief Development Officer | 29 | $16.8K | $17.8K | 2025-12-09 |
| FHMLSP, L.L.C. | 10% Owner | 1 | $0 | $0 | 2025-12-09 |
| Ozden Rabia Gurses | Director | 18 | $0 | $0 | 2025-12-09 |
| Lupher, Jr. Mark L. | Director | 19 | $175.5K | $0 | 2025-12-09 |
| Soparkar Peter | See Remarks section | 54 | $383.7K | $30.6K | 2025-12-09 |
| Nicholson, C. David | Director | 6 | $0 | $0 | 2025-12-09 |
| Svoronos Dawn | Director | 15 | $225.9K | $0 | 2025-12-09 |
| Tuckson Reed Vaughn | Director | 10 | $0 | $0 | 2025-12-09 |
| Fischer Laurent | CEO, President and Director | 56 | $925.2K | $94.4K | 2025-12-09 |
| Scopa James Paul | Director | 24 | $406.7K | $109.0K | 2025-12-09 |
| Rubinstein Linda M | Chief Financial Officer | 19 | $145.0K | $0 | 2025-12-09 |
| Machado Patrick | Director | 34 | $214.4K | $0 | 2025-12-09 |
| Whitcup Scott M | Director | 14 | $0 | $0 | 2025-12-09 |
| Leonard Braden Michael | 10% Owner | 24 | $6.19M | $4.61M | 2025-12-04 |
| Riley Brigit | Chief Scientific Officer | 6 | $0 | $13.5K | 2023-03-15 |
| Beckman Richard | Chief Medical Officer | 6 | $8.2K | $4.6K | 2023-03-01 |
| Rakow John | SVP, Genl Counsel, Acting CFO | 3 | $0 | $0 | 2022-09-14 |
| D'Souza Rupert | Chief Financial Officer | 3 | $16.9K | $0 | 2022-05-17 |
| Clark Julie | Chief Medical Officer | 3 | $0 | $10.3K | 2021-09-30 |
| Thedinga Angela | Chief Technology Officer | 4 | $0 | $0 | 2021-08-06 |
| Woiwode Thomas | Director | 16 | $0 | $0 | 2021-05-12 |
| Gasmi Mehdi | President and CSO | 68 | $0 | $2.42M | 2021-05-12 |
| Osborne Aaron | Chief Medical Officer | 3 | $0 | $0 | 2021-02-16 |
| PATTERSON LEONE D | SVP, CFO, Interim Pres and CEO | 30 | $0 | $2.17M | 2021-02-16 |
| Hemrajani Rekha | Director | 4 | $0 | $0 | 2020-06-23 |
| Carter Eric G | Director | 5 | $0 | $0 | 2020-06-23 |
| Leung Thomas | Chief Financial Officer | 2 | $0 | $0 | 2020-02-20 |
| Spivey Richard N. | Director | 6 | $0 | $0 | 2019-07-31 |
| Finer Mitchell H. | Other | 7 | $0 | $0 | 2019-07-31 |
| Cheng Jennifer C. | General Counsel | 3 | $0 | $0 | 2019-02-14 |
| Cleveland Paul B | Director | 4 | $0 | $0 | 2018-05-31 |
| Salzman Amber | President and COO | 6 | $0 | $0 | 2018-02-15 |
| Countouriotis Athena | SVP, Chief Medical Officer | 3 | $0 | $0 | 2018-02-15 |
| Schwartz Steven Daniel | Director | 2 | $0 | $0 | 2017-06-12 |
| Barone Samuel B. | SVP, Clinical Development | 4 | $0 | $0 | 2017-02-09 |
| Russo Carlo | EVP and Chief Medical Officer | 2 | $0 | $0 | 2016-05-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 21,040 | — | $0 | 0 | SEC↗ |
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 2,500 | — | $0 | 0 | SEC↗ |
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 1,250 | — | $0 | 0 | SEC↗ |
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 2,000 | — | $0 | 0 | SEC↗ |
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 8,000 | — | $0 | 0 | SEC↗ |
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| Kiss Szilard | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 2,500 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 1,000 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,360 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 6,476 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,500 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 1,500 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,000 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 5,250 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 5,250 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 5,250 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 13,820 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 13,590 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 7,000 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,000 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Nicholson, C. David | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Nicholson, C. David | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| Nicholson, C. David | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 8,000 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,666 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,000 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Tuckson Reed Vaughn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| Tuckson Reed Vaughn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Tuckson Reed Vaughn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Tuckson Reed Vaughn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| Tuckson Reed Vaughn | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Whitcup Scott M | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,000 | — | $0 | 0 | SEC↗ |
| Whitcup Scott M | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 6,000 | — | $0 | 0 | SEC↗ |
| Whitcup Scott M | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Whitcup Scott M | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Whitcup Scott M | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Whitcup Scott M | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| Whitcup Scott M | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Hong Soo | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| Hong Soo | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Hong Soo | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 8,000 | — | $0 | 0 | SEC↗ |
| Hong Soo | Director | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 35,000 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 85,000 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 62,083 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2025-12-09 | 2025-12-10 | 48,750 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 40,000 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 42,500 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 48,750 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 43,458 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 25,000 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 8,500 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | D To issuer deriv | 2025-12-09 | 2025-12-10 | 48,750 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | D To issuer deriv | 2025-12-09 | 2025-12-10 | 44,010 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | D To issuer deriv | 2025-12-09 | 2025-12-10 | 85,000 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | D To issuer deriv | 2025-12-09 | 2025-12-10 | 8,000 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,074 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 15,999 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 40,000 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 78,750 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 64,394 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 40,000 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 39,476 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 38,500 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 13,999 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-12-09 | 2025-12-10 | 45,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 93,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 200,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | M Exercise deriv | 2025-12-09 | 2025-12-10 | 150,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 120,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 68,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 45,499 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 63,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 67,502 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 58,497 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 31,500 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-12-09 | 2025-12-10 | 110,420 | — | $0 | 0 | SEC↗ |
| FHMLSP, L.L.C. | 10% Owner | U Tender | 2025-12-09 | 2025-12-09 | 4,288,949 | $3.56 | $15.27M | 0 | SEC↗ |
| Machado Patrick | Director | U Tender | 2025-12-09 | 2025-12-10 | 8,818 | — | $0 | 0 | SEC↗ |
| Lupher, Jr. Mark L. | Director | U Tender | 2025-12-09 | 2025-12-10 | 13,000 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | U Tender | 2025-12-09 | 2025-12-10 | 10,333 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | U Tender | 2025-12-09 | 2025-12-10 | 5,000 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | M Exercise | 2025-12-09 | 2025-12-10 | 48,750 | $4.20 | $204.8K | 61,150 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 61,150 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 42,000 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A Award | 2025-12-09 | 2025-12-10 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 8,125 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 88,332 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 8,125 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award | 2025-12-09 | 2025-12-10 | 85,000 | — | $0 | 88,332 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 54,874 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | U Tender | 2025-12-09 | 2025-12-10 | 8,125 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award | 2025-12-09 | 2025-12-10 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | U Tender | 2025-12-09 | 2025-12-10 | 85,000 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award | 2025-12-09 | 2025-12-10 | 150,000 | — | $0 | 157,333 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 157,333 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 13,125 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | U Tender | 2025-12-09 | 2025-12-10 | 80,189 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | U Tender | 2025-12-09 | 2025-12-10 | 522,666 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award | 2025-12-09 | 2025-12-10 | 500,000 | — | $0 | 522,666 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | U Tender | 2025-12-09 | 2025-12-10 | 25,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | U Tender | 2025-12-09 | 2025-12-10 | 351,513 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | M Exercise | 2025-12-09 | 2025-12-10 | 150,000 | $4.20 | $630.0K | 351,513 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | P Buy | 2025-12-08 | 2025-12-08 | 117,614 | $4.31 | $506.9K | 201,513 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | P Buy | 2025-12-05 | 2025-12-08 | 50,000 | $4.22 | $211.0K | 80,189 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | P Buy | 2025-12-05 | 2025-12-08 | 11,085 | $4.24 | $47.0K | 83,899 | SEC↗ |
| Leonard Braden Michael | 10% Owner | S Sale | 2025-12-04 | 2025-12-05 | 524,560 | $4.19 | $2.20M | 1,958,080 | SEC↗ |
| Leonard Braden Michael | 10% Owner | S Sale | 2025-12-03 | 2025-12-03 | 222,925 | $4.17 | $929.6K | 2,428,640 | SEC↗ |
| Leonard Braden Michael | 10% Owner | S Sale | 2025-12-02 | 2025-12-03 | 51,961 | $4.20 | $218.2K | 2,705,565 | SEC↗ |
| Leonard Braden Michael | 10% Owner | S Sale | 2025-12-01 | 2025-12-03 | 300,000 | $4.20 | $1.26M | 2,757,526 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 3,140 | — | $0 | 3,140 | SEC↗ |
| Nicholson, C. David | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Hong Soo | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Lupher, Jr. Mark L. | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Tuckson Reed Vaughn | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Whitcup Scott M | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Kiss Szilard | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 45,499 | — | $0 | 45,499 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 120,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 68,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 110,420 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 67,502 | — | $0 | 67,502 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 67,502 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 58,497 | — | $0 | 58,497 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 58,497 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 31,500 | — | $0 | 31,500 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 31,500 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 63,000 | — | $0 | 63,000 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 63,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-06-17 | 2025-06-20 | 110,420 | — | $0 | 110,420 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | D To issuer deriv | 2025-06-17 | 2025-06-20 | 45,499 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2025-06-17 | 2025-06-20 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | D To issuer deriv | 2025-06-17 | 2025-06-20 | 8,000 | — | $0 | 0 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2025-06-17 | 2025-06-20 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | D To issuer deriv | 2025-06-17 | 2025-06-20 | 4,000 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 85,000 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 35,000 | — | $0 | 0 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 42,500 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 8,500 | — | $0 | 0 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 25,500 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 15,999 | — | $0 | 15,999 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 15,999 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 13,999 | — | $0 | 13,999 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 45,000 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 4,074 | — | $0 | 4,074 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 4,074 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 40,000 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 13,000 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 23,092 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 23,092 | — | $0 | 23,092 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 16,384 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 16,384 | — | $0 | 16,384 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-06-17 | 2025-06-20 | 13,999 | — | $0 | 0 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-06-17 | 2025-06-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | D To issuer deriv | 2025-06-10 | 2025-06-20 | 40,000 | — | $0 | 0 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | S Sale | 2025-05-15 | 2025-05-16 | 9,126 | $2.00 | $18.3K | 87,488 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | S Sale | 2025-05-15 | 2025-05-16 | 924 | $2.00 | $1.8K | 13,768 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | S Sale | 2025-05-15 | 2025-05-16 | 2,960 | $2.00 | $5.9K | 39,154 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-04-23 | 2025-04-24 | 50,000 | $2.98 | $149.0K | 191,800 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-04-22 | 2025-04-24 | 300,000 | $3.00 | $900.0K | 3,057,526 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-04-02 | 2025-04-02 | 15,209 | $4.04 | $61.4K | 2,757,526 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-31 | 2025-04-02 | 19,566 | $4.38 | $85.7K | 2,742,317 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-27 | 2025-04-28 | 16,593 | $5.19 | $86.1K | 141,800 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-27 | 2025-04-28 | 16,593 | $5.19 | $86.1K | 141,800 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-27 | 2025-03-27 | 16,593 | $5.19 | $86.1K | 141,800 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-26 | 2025-04-28 | 20,407 | $5.04 | $102.9K | 125,207 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-26 | 2025-04-28 | 20,407 | $5.04 | $102.9K | 125,207 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-26 | 2025-03-27 | 20,407 | $5.04 | $102.9K | 125,207 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-20 | 2025-03-20 | 30,600 | $5.61 | $171.7K | 2,722,761 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-19 | 2025-03-20 | 25,000 | $4.94 | $123.5K | 2,692,161 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-18 | 2025-03-20 | 44,341 | $4.73 | $209.7K | 2,667,161 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-03-18 | 2025-03-20 | 18,000 | $4.60 | $82.8K | 2,622,820 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-02-28 | 2025-02-28 | 85,068 | $4.60 | $391.3K | 2,604,820 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-02-27 | 2025-02-28 | 86,802 | $4.46 | $387.1K | 2,519,752 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2025-02-26 | 2025-02-28 | 164,886 | $4.01 | $661.2K | 2,432,950 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2025-02-25 | 2025-02-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2025-02-25 | 2025-02-27 | 48,750 | — | $0 | 48,750 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-02-25 | 2025-02-27 | 48,750 | — | $0 | 48,750 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2025-02-25 | 2025-02-27 | 48,750 | — | $0 | 48,750 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2025-02-25 | 2025-02-27 | 78,750 | — | $0 | 78,750 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award | 2025-02-25 | 2025-02-27 | 25,000 | — | $0 | 96,614 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award | 2025-02-25 | 2025-02-27 | 8,125 | — | $0 | 8,125 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A Award | 2025-02-25 | 2025-02-27 | 8,125 | — | $0 | 19,325 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award | 2025-02-25 | 2025-02-27 | 8,125 | — | $0 | 14,692 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award | 2025-02-25 | 2025-02-27 | 13,125 | — | $0 | 42,114 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2024-08-02 | 2024-08-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2024-08-02 | 2024-08-06 | 64,394 | — | $0 | 64,394 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2024-08-02 | 2024-08-06 | 43,458 | — | $0 | 43,458 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-08-02 | 2024-08-06 | 62,083 | — | $0 | 62,083 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2024-08-02 | 2024-08-06 | 44,010 | — | $0 | 44,010 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2024-07-30 | 2024-07-31 | 85,800 | $7.15 | $613.5K | 2,268,064 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2024-07-18 | 2024-07-18 | 80,718 | $9.11 | $735.3K | 2,182,264 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2024-07-17 | 2024-07-18 | 135,546 | $7.75 | $1.05M | 2,101,546 | SEC↗ |
| Kiss Szilard | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 21,040 | — | $0 | 21,040 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Whitcup Scott M | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Tuckson Reed Vaughn | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Lupher, Jr. Mark L. | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Hong Soo | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Nicholson, C. David | Director | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| Ozden Rabia Gurses | Chief Medical Officer | A Award deriv | 2024-06-17 | 2024-06-20 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2024-02-12 | 2024-02-14 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-02-12 | 2024-02-14 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2024-02-12 | 2024-02-14 | 1,104,200 | — | $0 | 1,104,200 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2024-02-12 | 2024-02-14 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Lupher, Jr. Mark L. | Director | P Buy | 2024-02-07 | 2024-02-09 | 130,000 | $1.35 | $175.5K | 130,000 | SEC↗ |
| Scopa James Paul | Director | P Buy | 2024-02-07 | 2024-02-09 | 100,000 | $1.35 | $135.0K | 100,000 | SEC↗ |
| Nicholson, C. David | Director | A Award deriv | 2023-11-03 | 2023-11-06 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | A Award deriv | 2023-10-03 | 2024-03-12 | 315,000 | — | $0 | 315,000 | SEC↗ |
| Soparkar Peter | CHIEF OPERATING OFFICER | A Award deriv | 2023-10-03 | 2024-03-12 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2023-10-03 | 2024-03-12 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Seyedkazemi Setareh | Chief Development Officer | S Sale | 2023-09-15 | 2023-09-18 | 130 | $1.55 | $202 | 47,674 | SEC↗ |
| Seyedkazemi Setareh | Chief Development Officer | S Sale | 2023-09-15 | 2023-09-18 | 6,071 | $1.52 | $9.2K | 47,804 | SEC↗ |
| Rubinstein Linda M | Chief Financial Officer | A Award deriv | 2023-08-03 | 2023-09-05 | 850,000 | — | $0 | 850,000 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 12,500 | — | $0 | 52,500 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hong Soo | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Lupher, Jr. Mark L. | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Tuckson Reed Vaughn | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Whitcup Scott M | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Ozden Rabia Gurses | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rubinstein Linda M | Chief Financial Officer | P Buy | 2023-06-07 | 2023-06-09 | 100,000 | $1.45 | $145.0K | 100,000 | SEC↗ |
| Fischer Laurent | CEO, President and Director | S Sale | 2023-03-15 | 2023-03-17 | 41,239 | $0.78 | $32.2K | 692,141 | SEC↗ |
| Soparkar Peter | Chief Operating Officer | S Sale | 2023-03-15 | 2023-03-17 | 13,360 | $0.78 | $10.4K | 265,891 | SEC↗ |
| Riley Brigit | Chief Scientific Officer | S Sale | 2023-03-15 | 2023-03-17 | 7,299 | $0.78 | $5.7K | 117,435 | SEC↗ |
| Fischer Laurent | CEO, President and Director | A Award deriv | 2023-03-01 | 2023-03-03 | 930,000 | — | $0 | 930,000 | SEC↗ |
| Soparkar Peter | Chief Operating Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Beckman Richard | Chief Medical Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Seyedkazemi Setareh | Chief Development Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Riley Brigit | Chief Scientific Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Fischer Laurent | CEO, President and Director | S Sale | 2022-09-19 | 2022-09-21 | 41,082 | $1.07 | $44.0K | 727,380 | SEC↗ |
| Riley Brigit | Chief Scientific Officer | S Sale | 2022-09-19 | 2022-09-21 | 7,266 | $1.07 | $7.8K | 118,734 | SEC↗ |
| Soparkar Peter | See Remarks section | S Sale | 2022-09-19 | 2022-09-21 | 13,305 | $1.07 | $14.2K | 273,251 | SEC↗ |
| Seyedkazemi Setareh | Chief Development Officer | S Sale | 2022-09-19 | 2022-09-21 | 6,058 | $1.07 | $6.5K | 47,875 | SEC↗ |
| Beckman Richard | Chief Medical Officer | S Sale | 2022-09-19 | 2022-09-21 | 4,272 | $1.07 | $4.6K | 39,061 | SEC↗ |
| Fischer Laurent | CEO, President and Director | A Award deriv | 2022-09-14 | 2022-09-16 | 584,978 | — | $0 | 584,978 | SEC↗ |
| Fischer Laurent | CEO, President and Director | A Award deriv | 2022-09-14 | 2022-09-16 | 675,022 | — | $0 | 675,022 | SEC↗ |
| Soparkar Peter | See Remarks section | A Award deriv | 2022-09-14 | 2022-09-16 | 163,847 | — | $0 | 163,847 | SEC↗ |
| Soparkar Peter | See Remarks section | A Award deriv | 2022-09-14 | 2022-09-16 | 230,924 | — | $0 | 230,924 | SEC↗ |
| Rakow John | SVP, Genl Counsel, Acting CF | A Award deriv | 2022-09-14 | 2022-09-16 | 42,813 | — | $0 | 42,813 | SEC↗ |
| Rakow John | SVP, Genl Counsel, Acting CF | A Award deriv | 2022-09-14 | 2022-09-16 | 75,257 | — | $0 | 75,257 | SEC↗ |
| Riley Brigit | Chief Scientific Officer | A Award deriv | 2022-09-14 | 2022-09-16 | 95,931 | — | $0 | 95,931 | SEC↗ |
| Riley Brigit | Chief Scientific Officer | A Award deriv | 2022-09-14 | 2022-09-16 | 68,482 | — | $0 | 68,482 | SEC↗ |
| Seyedkazemi Setareh | Chief Development Officer | A Award | 2022-09-14 | 2022-09-16 | 33,333 | — | $0 | 53,933 | SEC↗ |
| Beckman Richard | Chief Medical Officer | A Award | 2022-09-14 | 2022-09-16 | 25,000 | — | $0 | 35,000 | SEC↗ |
| Beckman Richard | Chief Medical Officer | A Award | 2022-09-14 | 2022-09-21 | 33,333 | — | $0 | 43,333 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Whitcup Scott M | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Lupher, Jr. Mark L. | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Tuckson Reed Vaughn | Director | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rakow John | SVP, Genl Counsel, Acting CF | A Award deriv | 2022-06-08 | 2022-06-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Seyedkazemi Setareh | Chief Development Officer | P Buy | 2022-05-23 | 2022-05-24 | 20,000 | $0.84 | $16.8K | 20,600 | SEC↗ |
| D'Souza Rupert | Chief Financial Officer | P Buy | 2022-05-17 | 2022-05-17 | 10,000 | $0.83 | $8.3K | 20,850 | SEC↗ |
| Beckman Richard | Chief Medical Officer | P Buy | 2022-05-17 | 2022-05-19 | 10,000 | $0.82 | $8.2K | 10,000 | SEC↗ |
| Svoronos Dawn | Director | P Buy | 2022-05-16 | 2022-05-18 | 30,000 | $0.85 | $25.5K | 50,000 | SEC↗ |
| D'Souza Rupert | Chief Financial Officer | P Buy | 2022-05-13 | 2022-05-17 | 10,000 | $0.86 | $8.6K | 10,850 | SEC↗ |
| Fischer Laurent | CEO, President and Director | P Buy | 2022-04-20 | 2022-04-22 | 25,000 | $1.11 | $27.8K | 762,462 | SEC↗ |
| Soparkar Peter | See Remarks section | P Buy | 2022-04-19 | 2022-04-20 | 21,750 | $1.14 | $24.8K | 280,556 | SEC↗ |
| Soparkar Peter | See Remarks section | P Buy | 2022-04-19 | 2022-04-20 | 175 | $1.14 | $199 | 258,806 | SEC↗ |